Latest Crohn's disease Stories
"Get Your Full Course" addresses diet and nutritional considerations related to inflammatory bowel diseases and highlights Sunny's personal story of living with ulcerative colitis HORSHAM,
Presentations examine certain demographic and clinical disease characteristics that may be indicative of Cimzia® treatment response and remission for moderate to severe Crohn's disease ATLANTA,
Immune Pharmaceuticals Recently Initiated Phase II Clinical Trial in Ulcerative Colitis CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Oct.
Regarded as one of the world's leading experts in the field of pediatric inflammatory bowel disease (IBD), Marla Dubinsky, MD, has been appointed Chief of Pediatric Gastroenterology in the
SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- Meritage Pharma, Inc.
-- HUMIRA is now indicated to treat pediatric patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators
Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc.
Genetic changes that occur in patients with the bowel condition Crohn's disease could hold clues to fighting the illness.
At Weinberg Gastrointestinal, patients can now receive both American and Canadian screening colonoscopies in Gilbert, Arizona GILBERT, Ariz., Aug.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.